These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20017576)

  • 1. In silico toxicology challenges for pharmaceuticals: complacency or controversy?
    Cronin MT
    Altern Lab Anim; 2009 Nov; 37(5):453-6. PubMed ID: 20017576
    [No Abstract]   [Full Text] [Related]  

  • 2. The in chemico-in silico interface: challenges for integrating experimental and computational chemistry to identify toxicity.
    Cronin MT; Bajot F; Enoch SJ; Madden JC; Roberts DW; Schwöbel J
    Altern Lab Anim; 2009 Nov; 37(5):513-21. PubMed ID: 20017580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S
    ALTEX; 2012; 29(1):1. PubMed ID: 22408846
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology and stem cells: New frontiers.
    Caloni F; Ferrari M; De Angelis I
    ALTEX; 2014; 31(1):94. PubMed ID: 24448761
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: Bayesian network integrated testing strategy and beyond.
    Jaworska J
    ALTEX; 2013; 30(3):391. PubMed ID: 23861082
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 8. Special anniversary volume - issue 5: replacement - focus on in silico methods.
    Balls M
    Altern Lab Anim; 2009 Nov; 37(5):465-6. PubMed ID: 20166273
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in evaluation of chemicals toxicology safety and opportunity and status quo of research on animal experiment substitute method].
    Hou FX
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Aug; 26(8):502-5. PubMed ID: 19358771
    [No Abstract]   [Full Text] [Related]  

  • 10. Not a walk in the park: the ECVAM whole embryo culture model challenged with pharmaceuticals and attempted improvements with random forest design.
    Thomson J; Johnson K; Chapin R; Stedman D; Kumpf S; Ozolinš TR
    Birth Defects Res B Dev Reprod Toxicol; 2011 Apr; 92(2):111-21. PubMed ID: 21370399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
    Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Prueitt RL; Beck BD
    Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of computer models in pharmaceutical safety evaluation.
    Boyer S
    Altern Lab Anim; 2009 Nov; 37(5):467-75. PubMed ID: 20017577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R; Burkhardt J; Kadambi VJ
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
    Coecke S; Ahr H; Blaauboer BJ; Bremer S; Casati S; Castell J; Combes R; Corvi R; Crespi CL; Cunningham ML; Elaut G; Eletti B; Freidig A; Gennari A; Ghersi-Egea JF; Guillouzo A; Hartung T; Hoet P; Ingelman-Sundberg M; Munn S; Janssens W; Ladstetter B; Leahy D; Long A; Meneguz A; Monshouwer M; Morath S; Nagelkerke F; Pelkonen O; Ponti J; Prieto P; Richert L; Sabbioni E; Schaack B; Steiling W; Testai E; Vericat JA; Worth A
    Altern Lab Anim; 2006 Feb; 34(1):49-84. PubMed ID: 16522150
    [No Abstract]   [Full Text] [Related]  

  • 18. Call to curb lab tests on dogs.
    Turner M
    Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INVITOX 2004: 13th Workshop of the European Society of Toxicology In Vitro, organised in cooperation with the Scandinavian Society for Cell Toxicology.
    Kolman A
    Altern Lab Anim; 2004 Dec; 32(6):625-9. PubMed ID: 15757500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.